Protection against thrombosis in mice lacking PAR3

被引:148
作者
Weiss, EJ
Hamilton, JR
Lease, KE
Coughlin, SR
机构
[1] Univ Calif San Francisco, Cardiovasc Res Unit, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
关键词
D O I
10.1182/blood-2002-05-1470
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recent observation that knock-out of protease-activated receptor-4 (PAR4) ablates thrombin signaling in mouse platelets and protects against ferric chloride-induced thrombosis of mouse mesenteric arterioles suggests that thrombin's actions on platelets can play an important role in thrombosis. Complete ablation of thrombin signaling would be difficult to achieve in human beings because human platelets have 2 thrombin receptors that are each capable of mediating transmembrane signaling. However, it is possible that complete ablation of thrombin signaling in platelets is not necessary for an antithrombotic effect. In mouse platelets, PAR3 functions as a cofactor that binds thrombin and promotes productive cleavage of PAR4, and thrombin responses are decreased but not absent in Par3(-/-) platelets. We now report that Par3(-/-) mice were protected against ferric chloride-induced thrombosis of mesenteric arterioles and against thromboplastin-induced pulmonary embolism. Surprisingly, Par3(-/-) and Par4(-/-) mice showed similar degrees of protection in these models and similar prolongation of tall bleeding times. Thus, even a partial decrease in mouse platelet responsiveness to thrombin protected against thrombosis and impaired hemostasis in some settings. These results demonstrate the importance of PAR3's unusual cofactor function and underscore the relative importance of thrombin's actions on platelets in vivo. They also suggest that PAR inhibition might be explored for the prevention or treatment of thrombosis in human beings. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3240 / 3244
页数:5
相关论文
共 14 条
  • [1] Colman RW, 1994, HEMOSTASIS THROMBOSI, P3
  • [2] AN ANTIBODY AGAINST THE EXOSITE OF THE CLONED THROMBIN RECEPTOR INHIBITS EXPERIMENTAL ARTERIAL THROMBOSIS IN THE AFRICAN-GREEN MONKEY
    COOK, JJ
    SITKO, GR
    BEDNAR, B
    CONDRA, C
    MELLOTT, MJ
    FENG, DM
    NUTT, RF
    SHAFER, JA
    GOULD, RJ
    CONNOLLY, TM
    [J]. CIRCULATION, 1995, 91 (12) : 2961 - 2971
  • [3] A mouse model of severe von Willebrand disease:: Defects in hemostasis and thrombosis
    Denis, C
    Methia, N
    Frenette, PS
    Rayburn, H
    Ullman-Culleré, M
    Hynes, RO
    Wagner, DD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9524 - 9529
  • [4] Glantz SA, 1992, PRIMER BIOSTATISTICS
  • [5] Protease-activated receptor 3 is a second thrombin receptor in humans
    Ishihara, H
    Connolly, AJ
    Zeng, DW
    Kahn, ML
    Zheng, YW
    Timmons, C
    Tram, T
    Coughlin, SR
    [J]. NATURE, 1997, 386 (6624) : 502 - 506
  • [6] Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
    Kahn, ML
    Nakanishi-Matsui, M
    Shapiro, MJ
    Ishihara, H
    Coughlin, SR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) : 879 - 887
  • [7] A dual thrombin receptor system for platelet activation
    Kahn, ML
    Zheng, YW
    Huang, W
    Bigornia, V
    Zeng, DW
    Moff, S
    Farese, RV
    Tam, C
    Coughlin, SR
    [J]. NATURE, 1998, 394 (6694) : 690 - 694
  • [8] Léon C, 2001, CIRCULATION, V103, P718
  • [9] PAR3 is a cofactor for PAR4 activation by thrombin
    Nakanishi-Matsui, M
    Zheng, YW
    Sulciner, DJ
    Weiss, EJ
    Ludeman, MJ
    Coughlin, SR
    [J]. NATURE, 2000, 404 (6778) : 609 - +
  • [10] Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody - Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and ''clinical restenosis''
    Reverter, JC
    Beguin, S
    Kessels, H
    Kumar, R
    Hemker, HC
    Coller, BS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) : 863 - 874